Get started
Author

Hayden P. Huggins

Observed names: H.P. Huggins, Hayden Huggins, Hayden P Huggins, Huggins, Hayden P.
Observed institutions: University of North Carolina at Chapel Hill, North Carolina State University, East Carolina University, Vanderbilt University, UNC Lineberger Comprehensive Cancer Center, Revance (United States)
ORCID: 0009-0006-7091-3528
Observed ORCID: 0009-0006-7091-3528
OpenAlex ID: A5047752214
A first-in-class EGFR-directed KRAS G12V selective inhibitor
2025 · Lyla J. Stanland, Hayden P. Huggins, et al. · Cancer Cell · 39
Distinct roles of two eIF4E isoforms in the germline of Caenorhabditis elegans
2020 · Hayden P. Huggins, Jacob S. Subash, et al. · Journal of Cell Science · 38
PDF
Silencing of Oncogenic KRAS by Mutant-Selective Small Interfering RNA
2021 · Bjoern Papke, Salma H. Azam, et al. · ACS Pharmacology & Translational Science · 26
PDF
Regulation of Germ Cell mRNPs by eIF4E:4EIP Complexes: Multiple Mechanisms, One Goal
2020 · Hayden P. Huggins, Brett D. Keiper · Frontiers in Cell and Developmental Biology · 16
PDF
Inverted chimeric RNAi molecules synergistically cotarget MYC and KRAS in KRAS-driven cancers
2025 · Yogitha S. Chareddy, Hayden P. Huggins, et al. · Journal of Clinical Investigation · 12
PDF
Two eIF4E paralogs occupy separate germ granule messenger ribonucleoproteins that mediate mRNA repression and translational activation
2025 · Gita Gajjar, Hayden P Huggins, et al. · Genetics · 5
Remodeling of Germ Cell mRNPs for Translational Control
2025 · Brett D. Keiper, Hayden P. Huggins · Biology · 2
PDF
P2.11-03 Synergistic Co-Targeting Of MYC And KRAS In Lung Cancer By Novel Ligand-Directed Inverted Chimeric RNAi Molecules
2023 · Y. Chareddy, H.P. Huggins, et al. · Journal of Thoracic Oncology · 2
PDF
Abstract 4307: A first-in-class EGFR-directed KRAS G12V selective inhibitor
2025 · Lyla Stanland, Hayden Huggins, et al. · Cancer Research · 1
Abstract PR012: A first-in-class EGFR-directed KRAS G12V selective inhibitor
2024 · Lyla Stanland, Hayden Huggins, et al. · Molecular Cancer Therapeutics · 1
Abstract 1329: Preclinical development of EFTX-G12V, a first-in-class EGFR-directed KRAS G12V selective inhibitor.
2026 · Lyla J. Stanland, Hayden Huggins, et al. · Cancer Research
Inverted chimeric RNAi molecules synergistically co-target MYC and KRAS in KRAS-driven cancers
2025 · Im, Jonah, Huggins, Hayden P., et al. · UNC Libraries
THE DISTINCT ROLES OF TWO eIF4E ISOFORMS AND THEIR COGNATE 4EIPS IN THE GERMLINE OF C. elegans
2020 · Hayden P. Huggins · The Scholarship East Carolina University's Institutional Repository (East Carolina University)
Works count: 13
Citation count: 142
H-index: 5
I10-index: 5
Year
Topic
Type